Company | Name | Exchange | Sector | Industry | Market Cap | P/E Ratio | PEG Ratio | Last Trade Price | Day Change (%) | Fair Value | Fair Value Upside | Fair Value Label | Analyst Price Target | Analyst Target Upside | Overall Health |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Celltrion | Seoul | Healthcare | Biotechnology & Medical Research | ₩35.43T | 67.6x | 59.95 | ₩160,200 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 38% Upside | Upgrade to Pro+ | |
LigaChem Biosciences | KOSDAQ | Healthcare | Biotechnology & Medical Research | ₩3.96T | 171x | 1.18 | ₩109,800 | 0.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 35.1% Upside | Upgrade to Pro+ | |
ABL Bio | KOSDAQ | Healthcare | Biotechnology & Medical Research | ₩3.86T | -53.5x | 0.66 | ₩78,900 | -0.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | -0.7% Downside | Upgrade to Pro+ | |
Peptron | KOSDAQ | Healthcare | Biotechnology & Medical Research | ₩3.74T | -226.2x | 9.01 | ₩169,000 | 5.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
TissueGene | KOSDAQ | Healthcare | Biotechnology & Medical Research | ₩3.17T | ₩39,350 | 1.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||||
Voronoi | KOSDAQ | Healthcare | Biotechnology & Medical Research | ₩1.83T | -45.3x | 16.7 | ₩99,700 | -2.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Seegene | KOSDAQ | Healthcare | Biotechnology & Medical Research | ₩1.49T | 141x | 0.36 | ₩32,550 | 0.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 28.4% Upside | Upgrade to Pro+ | |
GI Innovation | KOSDAQ | Healthcare | Biotechnology & Medical Research | ₩1.11T | ₩18,230 | 1.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||||
OliX Pharmaceuticals | KOSDAQ | Healthcare | Biotechnology & Medical Research | ₩922.52B | -20.8x | 0.22 | ₩48,050 | 3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Curiox BioSystems | KOSDAQ | Healthcare | Biotechnology & Medical Research | ₩538.57B | -40.5x | 5.24 | ₩32,300 | -3.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
SillaJen | KOSDAQ | Healthcare | Biotechnology & Medical Research | ₩450.99B | -16.1x | -4.45 | ₩3,325 | 1.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Bioneer | KOSDAQ | Healthcare | Biotechnology & Medical Research | ₩413.74B | -20.5x | 0.26 | ₩16,010 | -0.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Curocell | KOSDAQ | Healthcare | Biotechnology & Medical Research | ₩403.92B | -12.1x | ₩28,200 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |||
AprilBio | KOSDAQ | Healthcare | Biotechnology & Medical Research | ₩394.23B | ₩17,500 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||||
Medipost | KOSDAQ | Healthcare | Biotechnology & Medical Research | ₩349.51B | -4.8x | 0 | ₩10,220 | -0.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Genomictree | KOSDAQ | Healthcare | Biotechnology & Medical Research | ₩315.42B | -30.1x | -1.24 | ₩12,980 | -1.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Nibec | KOSDAQ | Healthcare | Biotechnology & Medical Research | ₩294.56B | -25.3x | ₩27,200 | 1.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |||
ToolGen | KOSDAQ | Healthcare | Biotechnology & Medical Research | ₩267.7B | 37.6x | 0.35 | ₩31,250 | 0.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Onconic Therapeutics | KOSDAQ | Healthcare | Biotechnology & Medical Research | ₩246.45B | -1.3x | ₩21,700 | -3.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |||
JS Link | KOSDAQ | Healthcare | Biotechnology & Medical Research | ₩245.5B | -12.9x | 0.08 | ₩9,720 | 6.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
PharmAbcine | KOSDAQ | Healthcare | Biotechnology & Medical Research | ₩233.76B | -0.57 | ₩2,915 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |||
Vaxcell | KOSDAQ | Healthcare | Biotechnology & Medical Research | ₩229.78B | ₩10,040 | 1.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||||
GeneOne Life Science | Seoul | Healthcare | Biotechnology & Medical Research | ₩228.71B | -5.8x | -0.17 | ₩2,695 | -0.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Genexine | KOSDAQ | Healthcare | Biotechnology & Medical Research | ₩225.58B | -3.5x | ₩4,965 | 0.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |||
3Billion | KOSDAQ | Healthcare | Biotechnology & Medical Research | ₩221.73B | ₩7,070 | 1.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||||
AptaBio Therapeutics | KOSDAQ | Healthcare | Biotechnology & Medical Research | ₩212.09B | -7x | 0.06 | ₩7,840 | -0.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Amicogen | KOSDAQ | Healthcare | Biotechnology & Medical Research | ₩207.75B | -4.9x | 0.12 | ₩3,875 | 2.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
NKMAX | KOSDAQ | Healthcare | Biotechnology & Medical Research | ₩172.74B | -0.08 | ₩2,020 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |||
Macrogen | KOSDAQ | Healthcare | Biotechnology & Medical Research | ₩172.38B | -20.6x | -0.35 | ₩15,990 | 0.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Tiumbio | KOSDAQ | Healthcare | Biotechnology & Medical Research | ₩164.4B | -7.6x | 0.54 | ₩6,220 | 1.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
OnCoCross | KOSDAQ | Healthcare | Biotechnology & Medical Research | ₩162.51B | -20.9x | 1.74 | ₩13,630 | -0.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
HEM Pharma | KOSDAQ | Healthcare | Biotechnology & Medical Research | ₩158.83B | ₩22,600 | -0.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||||
Prestige Biopharma | Seoul | Healthcare | Biotechnology & Medical Research | ₩155.77B | 36.7x | -0.16 | ₩12,920 | -0.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Abion | KOSDAQ | Healthcare | Biotechnology & Medical Research | ₩150.63B | -2.8x | 0.1 | ₩5,270 | 0.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Cellid | KOSDAQ | Healthcare | Biotechnology & Medical Research | ₩148.56B | ₩7,000 | -0.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||||
ENCell | KOSDAQ | Healthcare | Biotechnology & Medical Research | ₩140.95B | ₩12,990 | 0.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||||
iNtRON Biotechnology | KOSDAQ | Healthcare | Biotechnology & Medical Research | ₩137.68B | -34.6x | -0.63 | ₩4,325 | -0.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
HLB BioStep | KOSDAQ | Healthcare | Biotechnology & Medical Research | ₩132.28B | -16.5x | 0.1 | ₩1,575 | 0.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
CJ Bioscience | KOSDAQ | Healthcare | Biotechnology & Medical Research | ₩132.22B | -3.3x | 0.75 | ₩10,030 | -0.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Medpacto | KOSDAQ | Healthcare | Biotechnology & Medical Research | ₩130.25B | -8.4x | -0.13 | ₩4,020 | 5.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Neoimmunetech | KOSDAQ | Healthcare | Biotechnology & Medical Research | ₩124.57B | -0.03 | ₩1,257 | -0.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |||
Kang Stem Biotech | KOSDAQ | Healthcare | Biotechnology & Medical Research | ₩113.51B | -10.6x | -0.15 | ₩2,055 | 1.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Orientbio | Seoul | Healthcare | Biotechnology & Medical Research | ₩109.68B | -26.4x | ₩918 | -0.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |||
Dx Vx | KOSDAQ | Healthcare | Biotechnology & Medical Research | ₩106.8B | -2x | 0.29 | ₩2,165 | -0.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Shaperon | KOSDAQ | Healthcare | Biotechnology & Medical Research | ₩103.69B | -7.9x | -0.31 | ₩3,540 | 2.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Panagene | KOSDAQ | Healthcare | Biotechnology & Medical Research | ₩102.11B | -33.1x | ₩2,330 | 1.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |||
GL Pharm Tech | KOSDAQ | Healthcare | Biotechnology & Medical Research | ₩99.29B | -146.2x | -1.65 | ₩1,294 | 0.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Noul | KOSDAQ | Healthcare | Biotechnology & Medical Research | ₩91.81B | -3.8x | 0.16 | ₩2,450 | -1.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Cell Biotech | KOSDAQ | Healthcare | Biotechnology & Medical Research | ₩90.61B | 6.3x | 0.06 | ₩13,200 | -0.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Pharos IBio | KOSDAQ | Healthcare | Biotechnology & Medical Research | ₩89.59B | -8.1x | 2.1 | ₩6,970 | 0.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ |